Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | NLRP3 | Q96P20 | 7/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | CTSA | P10619 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3943579 | 0.84 | P2RX7 (0.54) | CYP1A2NLRP3ALDH1A1MAPTMGAM | |
| SCHEMBL18593230 | 0.82 | CYP1A2 (0.50) | CYP1A2NLRP3ALDH1A1MAPTMGAM | |
| SCHEMBL1545927 | 0.82 | CYP1A2 (0.63) | CYP1A2ALDH1A1MAPTMGAMGAA | |
| SCHEMBL24141795 | 0.82 | CYP1A2 (0.50) | CYP1A2NLRP3ALDH1A1MAPTMGAM | |
| SCHEMBL5751063 | 0.82 | CYP1A2 (0.50) | CYP1A2NLRP3ALDH1A1CTSAMAPT | |
| SCHEMBL31337797 | 0.81 | CYP1A2 (0.77) | CYP1A2ALDH1A1MAPTGAASMN1; SMN2 | |
| SCHEMBL1095857 | 0.81 | CYP1A2 (0.77) | CYP1A2ALDH1A1MAPTGAASMN1; SMN2 | |
| SCHEMBL15661105 | 0.81 | CYP1A2 (0.49) | CYP1A2NLRP3ALDH1A1CTSAMAPT | |
| SCHEMBL20028746 | 0.78 | P2RX7 (0.55) | CYP1A2ALDH1A1MAPTSMN1; SMN2MAPK1 | |
| SCHEMBL29036215 | 0.77 | GAA (0.42) | CYP1A2NLRP3ALDH1A1MAPTMGAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6982348-B2 | Aminoethanol derivatives | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-01-03 | — | — | US | disclosed |
| US-20040127574-A1 | Aminoethanol derivatives | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-07-01 | — | — | US | disclosed |
| EP-1362846-A1 | AMINOETHANOL DERIVATIVES | Takeda Chemical Industries, Ltd. (JP) | 2003-11-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040127574-A1 | Aminoethanol derivatives | CETP, LCAT, MTTP | CYP1A2 853/4885NLRP3 4321/4885ALDH1A1 783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.